Optical Coherence Tomography

About OCT

Optical Coherence Tomography (OCT) is a high resolution, noninvasive 3D-imaging technique employing light. OCT is often referred to as the ‘optical analogue’ of ultrasound imaging. Similar to ultrasound imaging, OCT creates a cross sectional (or 3D) image of tissue from the depth resolved backscattered intensity. The major difference between OCT and ultrasound imaging, is that OCT uses light, instead of sound. This has the direct consequence that the resolution is many times better in OCT (in the order of 1 to several micrometers), but the imaging depth in tissue is lower (maximally 2 mm).

Image: OCT B-scans of muscular tissue (left) and fatty tissue (right).

OCT research at BMPI

At BMPI, we go beyond imaging with OCT. By investigating the spectroscopic content of the OCT signal at every depth inside the tissue of interest, we perform depth-resolved spectroscopy. Spectroscopy relates the wavelength dependent absorption and scattering of tissue to its chemical composition. As a result, we not only obtain structural information about the tissue of interest, but also chemical information.

This functional extension of OCT, called spectroscopic OCT (sOCT) or low-coherence spectroscopy (LCS) has two major advantages compared to conventional (diffuse) reflectance spectroscopy: 1) it is localized, since we exactly know the depth from which our spectroscopic signal originates inside the tissue, and 2) it is quantitative, since we do not have make any assumptions on the optical path length that the light has traveled when calculating the optical absorption and/or scattering inside tissue.

Noninvasive blood analysis in newborns by spectroscopic OCT

Jaundice is a common and often harmless clinical condition in newborns, related to elevated concentrations of bilirubin in blood and extravascular tissue. However, in the case of severe jaundice, there is a high risk of bilirubin extravasation into the brain, causing irreversible brain damage (kernicterus) to the patient. Newborns at risk of severe jaundice are therefore subject to frequent invasive blood sampling. If the blood bilirubin concentration exceeds the acceptable limits, immediate treatment (i.e. phototherapy or exchange transfusion) is started. Invasive blood sampling is related to pain, stress, substantial blood loss and increased risk of infections – all factors that have been proven to impair the growth and development of this extremely vulnerable patient group.

A possible alternative to invasive blood testing is optical spectroscopy: the wavelength dependent analysis of remitted light from skin. This is a fast, noninvasive technique, sensitive to the concentration dependent absorption of light by bilirubin. Transcutaneous bilirubinometers are based on this principle and are currently applied to effectively reduce the number of required invasive blood samples for bilirubin determinations in the clinic. Unfortunately, they cannot replace all invasive blood samples, as their accuracy is inherently limited by the fact that they measure the skin concentration of bilirubin. This skin concentration is not directly (one to one) related to the blood concentration that is used for medical decision making.

In this project, we use visible sOCT to confine the spectroscopic measurement volume to blood only, for instance a single blood vessel. In that way, we exclude the background disturbance of extravasated bilirubin in the skin and measure the bilirubin concentration in blood directly. With that, we hope to achieve the highest possible measurement accuracy for noninvasive bilirubinometry, and reduce as many invasive blood samples as possible.


dr.ir. N. Bosschaart (Nienke) Dr.ir.
Associate Professor - Principal investigator
C.A. Cuartas Velez MSc (Carlos)
PhD Candidate
David Versteegen BSc
Master Student

PUBLICATIONS - Optical diagnosis of neonatal jaundice

  1. A.J. Dam-Vervloet, M.D van Erk, N. Doorn, S.G.J. Lip, N.A. Timmermans, L. Vanwinsen, F.A. de Boer, H.L.M. van Straaten, N. Bosschaart, Inter-device reproducibility of transcutaneous bilirubin meters, Pediatric Research (2020), https://www.nature.com/articles/s41390-020-01118-6
  2. M.D. van Erk, A.J. Dam-Vervloet, F.A. de Boer, M.F. Boomsma, H. van Straaten, N. Bosschaart, How skin anatomy influences transcutaneous bilirubin determinations: an in vitro evaluation, Pediatric Research 86(4), 471-477 (2019), doi: https://doi.org/10.1038/s41390-019-0471-z
  3. C. Veenstra, W. Petersen, I.M. Vellekoop, W. Steenbergen, N. Bosschaart, Spatially confined quantification of bilirubin concentrations by spectroscopic visible-light optical coherence tomography, Biomedical Optics Express 9(8), 3581-3589 (2019), doi: https://doi.org/10.1364/BOE.9.003581
  4. N. Bosschaart, J.H. Kok, A.M. Newsum, D.M. Ouweneel, R. Mentink, T.G. van Leeuwen, M.C.G. Aalders, Limitations and opportunities of transcutaneous bilirubin measurements, Pediatrics 129, 689-694 (2012), doi: 10.1542/peds.2011-2586 


  1. C. Veenstra, D. Every, W. Petersen, J.B. van Goudoever, W. Steenbergen, N. Bosschaart, Dependency of the optical scattering properties of human milk on casein content and common sample preparation methods, Journal of Biomedical Optics 25(4), 045001 (2020), doi: https://doi.org/10.1117/1.JBO.25.4.045001
  2. C. Veenstra, S. Kruitwagen, D. Groener, W. Petersen, W. Steenbergen, N. Bosschaart, Quantification of total haemoglobin concentrations in human whole blood by spectroscopic visible-light optical coherence tomography, Scientific Reports 9(1), 1-8 (2019), doi: https://doi.org/10.1038/s41598-019-51721-9
  3. C. Veenstra, A. Lenferink, W. Petersen, W. Steenbergen, N. Bosschaart, Optical properties of human milk, Biomedical Optics Express 10(8), 4059-4074 (2019), doi: https://doi.org/10.1364/BOE.10.004059
  4. C. Veenstra, W. Petersen, I.M. Vellekoop, W. Steenbergen, N. Bosschaart, Spatially confined quantification of bilirubin concentrations by spectroscopic visible-light optical coherence tomography, Biomedical Optics Express 9(8), 3581-3589 (2019), doi: https://doi.org/10.1364/BOE.9.003581
  5. N. Bosschaart, T.G. van Leeuwen, M.C.G. Aalders, D.J. Faber, Quantitative comparison of analysis methods for spectroscopic optical coherence tomography, Biomedical Optics Express 4, 2570-2584 (2013), doi: https://doi.org/10.1364/BOE.4.002570
  6. N. Bosschaart, M.C.G. Aalders, T.G. van Leeuwen, D.J. Faber, Spectral domain detection in low-coherence spectroscopy, Biomedical Optics Express 3, 2263-2272 (2012), doi: https://doi.org/10.1364/BOE.3.002263
  7. N. Bosschaart, D.J. Faber, T.G. van Leeuwen, M.C.G. Aalders, In vivo low-coherence spectroscopic measurements of local hemoglobin absorption spectra in human skin, Journal of Biomedical Optics 16, 100504 (2011), doi: https://doi.org/10.1117/1.3644497
  8. N. Bosschaart, D.J. Faber, T.G. van Leeuwen, M.C.G. Aalders, Measurements of wavelength dependent scattering and backscattering coefficients by low-coherence spectroscopy, Journal of Biomedical Optics 16, 030503 (2011), https://doi.org/10.1117/1.3553005
  9. N. Bosschaart, M.C.G. Aalders, D.J. Faber, J.J.A. Weda, M.J.C. van Gemert, T.G. van Leeuwen, Quantitative measurements of absorption spectra in scattering media by low-coherence spectroscopy, Optics Letters 34, 3746-3748 (2009), https://doi.org/10.1364/OL.34.003746



 Students who received awards on this project:

Alumni and former team members

PhD Students

Master Students

Bachelor Students